Does TOFACITINIB Cause Intestinal obstruction? 134 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Intestinal obstruction have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
134
Reports of Intestinal obstruction with TOFACITINIB
0.1%
of all TOFACITINIB reports
6
Deaths
91
Hospitalizations
How Dangerous Is Intestinal obstruction From TOFACITINIB?
Of the 134 reports, 6 (4.5%) resulted in death, 91 (67.9%) required hospitalization, and 20 (14.9%) were considered life-threatening.
Is Intestinal obstruction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 134 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Intestinal obstruction?
ADALIMUMAB (5,727)
VEDOLIZUMAB (1,263)
SEMAGLUTIDE (924)
INFLIXIMAB (907)
RISANKIZUMAB-RZAA (853)
BEVACIZUMAB (686)
LENALIDOMIDE (504)
CLOZAPINE (484)
OCTREOTIDE (463)
USTEKINUMAB (459)
Which TOFACITINIB Alternatives Have Lower Intestinal obstruction Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN